TP53 and lymphoma: TP53 mutations occurred in 6% of EBV positive lymphoma cases (3/47), while EBV negative PBLs harbored TP53 mutations in 24% (9/38) (p = 0.011, q = 0.193, Wilcoxon test; Supplementary Data 5).